Modern Radiotherapy for High-Risk and Very-High-Risk Prostate Adenocarcinoma

Modern radiotherapy for high-risk prostate cancer offers fewer treatments, selectively higher doses, elective pelvic nodal treatment, and the potential for intensification of androgen-deprivation therapy as well. There are active studies to better intensify or deintensify radiotherapy and androgen deprivation therapy based on novel genomic risk stratification tools.